World Orphan Drugs Rare Disease Congress
GCT is taking part in World Orphan Drugs Rare Disease Congress.
The World Orphan Drug Congress USA is a digital media and events platform for the rare disease community.
Nataliya Katsnelson, Senior Director of Business Development, is representing GCT in panel discussions, round tables, and keynote presentations.
Reach out to Nataliya to find more about placing clinical trials in the current situation.
Updated: March 3, 2021
Permanent link: https://2022.gctrials.com/posts/world-orphan-drugs-rare-disease-congress/